Perrigo reported $3.29B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
AbbVie USD 70.82B 2.04B Jun/2026
Abbott USD 34.05B 20.19B Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Corcept Therapeutics USD 8.99M 430K Sep/2026
Dr.Reddys Laboratories INR 71.95B 5.39B Jun/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
J&J USD 49.04B 5.95B Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Nestle CHF 62.85B 4.99B Jun/2026
Pacira USD 293.59M 69.53M Sep/2026
Perrigo USD 3.29B 337.7M Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 2.07B 1.02B Jun/2026
Reckitt Benckiser GBP 8.66B 238M Dec/2024
Sanofi EUR 23.58B 3.56B Jun/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026
Xeris Pharmaceuticals USD 289.44M 30.89M Jun/2026
Zoetis USD 9.24B 0 Jun/2026